Bioventus, Inc. (BVS)
9.95
-0.67
(-6.31%)
USD |
NASDAQ |
Nov 19, 16:00
9.96
+0.01
(+0.10%)
After-Hours: 20:00
Bioventus Debt to Equity Ratio : 1.015 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.015 |
| June 30, 2026 | 1.155 |
| March 31, 2026 | 1.527 |
| December 31, 2025 | 1.691 |
| September 30, 2025 | 2.054 |
| June 30, 2025 | 2.237 |
| March 31, 2025 | 2.402 |
| December 31, 2024 | 2.407 |
| September 30, 2024 | 2.652 |
| June 30, 2024 | 2.616 |
| March 31, 2024 | 2.364 |
| December 31, 2023 | 2.359 |
| September 30, 2023 | 2.31 |
| June 30, 2023 | 2.196 |
| March 31, 2023 | 2.456 |
| Date | Value |
|---|---|
| December 31, 2022 | 1.340 |
| September 30, 2022 | 1.287 |
| June 30, 2022 | 0.8787 |
| March 31, 2022 | 0.8636 |
| December 31, 2021 | 0.8198 |
| September 30, 2021 | 1.283 |
| June 30, 2021 | 1.413 |
| March 31, 2021 | 1.433 |
| December 31, 2020 | 1.437 |
| September 30, 2020 | 1.454 |
| June 30, 2020 | 1.869 |
| March 31, 2020 | |
| December 31, 2019 | 1.499 |
| September 30, 2019 | |
| March 31, 2016 | 1.102 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Accuray, Inc. | 2.560 |
| Orthofix Medical, Inc. | 0.6101 |
| ResMed, Inc. | 0.1027 |
| Rockwell Medical, Inc. | 0.4084 |
| Microbot Medical, Inc. | 0.0132 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 673.43M |
| Total Liabilities (Quarterly) | 381.56M |
| Shareholders Equity (Quarterly) | 240.50M |
| Current Ratio | 1.684 |
| Net Debt Paydown Yield | 2.50% |